Skip to main content
Erschienen in: Diabetologia 10/2006

01.10.2006 | Article

Early diabetes-induced biochemical changes in the retina: comparison of rat and mouse models

verfasst von: I. G. Obrosova, V. R. Drel, A. K. Kumagai, C. Szábo, P. Pacher, M. J. Stevens

Erschienen in: Diabetologia | Ausgabe 10/2006

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

Recently, various transgenic and knock-out mouse models have become available for studying the pathogenesis of diabetic retinopathy. At the same time, diabetes-induced retinal changes in the wild-type mice remain poorly characterised. The present study compared retinal biochemical changes in rats and mice with similar (6-week) durations of streptozotocin-induced diabetes.

Materials and methods

The experiments were performed on Wistar rats and C57Bl6/J mice. Retinal glucose, sorbitol, fructose, lactate, pyruvate, glutamate, α-ketoglutarate and ammonia were measured spectrofluorometrically by enzymatic methods. Vascular endothelial growth factor (VEGF) protein was assessed by ELISA, and poly(ADP-ribosyl)ation by immunohistochemistry and western blot analysis. Free mitochondrial and cytosolic NAD+/NADH ratios were calculated from the glutamate and lactate dehydrogenase systems.

Results

Retinal glucose concentrations were similarly increased in diabetic rats and mice, vs controls. Diabetic rats manifested ∼26- and 5-fold accumulation of retinal sorbitol and fructose, respectively, whereas elevation of both metabolites in diabetic mice was quite modest. Correspondingly, diabetic rats had (1) increased retinal malondialdehyde plus 4-hydroxyalkenal concentrations, (2) reduced superoxide dismutase (SOD), glutathione peroxidase, glutathione reductase and glutathione transferase activities, (3) slightly increased poly(ADP-ribose) immunoreactivity and poly(ADP-ribosyl)ated protein abundance, and (4) VEGF protein overexpression. Diabetic mice lacked these changes. SOD activity was 21-fold higher in murine than in rat retinas (the difference increased to 54-fold under diabetic conditions), whereas other antioxidative enzyme activities were 3- to 10-fold lower. With the exception of catalase, the key antioxidant defence enzyme activities were increased, rather than reduced, in diabetic mice. Diabetic rats had decreased free mitochondrial and cytosolic NAD+/NADH ratios, consistent with retinal hypoxia, whereas both ratios remained in the normal range in diabetic mice.

Conclusions/interpretation

Mice with short-term streptozotocin-induced diabetes lack many biochemical changes that are clearly manifest in the retina of streptozotocin-diabetic rats. This should be considered when selecting animal models for studying early retinal pathology associated with diabetes.
Literatur
2.
Zurück zum Zitat Frank RN, Amin R, Kennedy A, Hohman TC (1997) An aldose reductase inhibitor and aminoguanidine prevent vascular endothelial growth factor expression in rats with long-term galactosemia. Arch Ophthalmol 115:1036–1047PubMed Frank RN, Amin R, Kennedy A, Hohman TC (1997) An aldose reductase inhibitor and aminoguanidine prevent vascular endothelial growth factor expression in rats with long-term galactosemia. Arch Ophthalmol 115:1036–1047PubMed
3.
Zurück zum Zitat Kato N, Yashima S, Suzuki T, Nakayama Y, Jomori T (2003) Long-term treatment with fidarestat suppresses the development of diabetic retinopathy in STZ-induced diabetic rats. J Diabetes Complications 17:374–379PubMedCrossRef Kato N, Yashima S, Suzuki T, Nakayama Y, Jomori T (2003) Long-term treatment with fidarestat suppresses the development of diabetic retinopathy in STZ-induced diabetic rats. J Diabetes Complications 17:374–379PubMedCrossRef
4.
Zurück zum Zitat Dagher Z, Park YS, Asnaghi V, Hoehn T, Gerhardinger C, Lorenzi M (2004) Studies of rat and human retinas predict a role for the polyol pathway in human diabetic retinopathy. Diabetes 53:2404–2411PubMedCrossRef Dagher Z, Park YS, Asnaghi V, Hoehn T, Gerhardinger C, Lorenzi M (2004) Studies of rat and human retinas predict a role for the polyol pathway in human diabetic retinopathy. Diabetes 53:2404–2411PubMedCrossRef
5.
Zurück zum Zitat Kern TS, Tang J, Mizutani M et al (2000) Response of capillary cell death to aminoguanidine predicts the development of retinopathy: comparison of diabetes and galactosemia. Invest Ophthalmol Vis Sci 41:3972–3978PubMed Kern TS, Tang J, Mizutani M et al (2000) Response of capillary cell death to aminoguanidine predicts the development of retinopathy: comparison of diabetes and galactosemia. Invest Ophthalmol Vis Sci 41:3972–3978PubMed
6.
Zurück zum Zitat Ellis EA, Guberski DL, Hutson B, Grant MB (2002) Time course of NADH oxidase, inducible nitric oxide synthase and peroxynitrite in diabetic retinopathy in the BBZ/WOR rat. Nitric Oxide 6:295–304PubMedCrossRef Ellis EA, Guberski DL, Hutson B, Grant MB (2002) Time course of NADH oxidase, inducible nitric oxide synthase and peroxynitrite in diabetic retinopathy in the BBZ/WOR rat. Nitric Oxide 6:295–304PubMedCrossRef
7.
Zurück zum Zitat Abiko T, Abiko A, Clermont AC et al (2003) Characterization of retinal leukostasis and hemodynamics in insulin resistance and diabetes: role of oxidants and protein kinase-C activation. Diabetes 52:829–837PubMedCrossRef Abiko T, Abiko A, Clermont AC et al (2003) Characterization of retinal leukostasis and hemodynamics in insulin resistance and diabetes: role of oxidants and protein kinase-C activation. Diabetes 52:829–837PubMedCrossRef
8.
Zurück zum Zitat Aiello LP, Bursell SE, Clermont A et al (1997) Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective beta-isoform-selective inhibitor. Diabetes 46:1473–1480PubMedCrossRef Aiello LP, Bursell SE, Clermont A et al (1997) Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective beta-isoform-selective inhibitor. Diabetes 46:1473–1480PubMedCrossRef
9.
Zurück zum Zitat Obrosova IG, Minchenko AG, Marinescu V et al (2001) Antioxidants attenuate early up regulation of retinal vascular endothelial growth factor in streptozotocin-diabetic rats. Diabetologia 44:1102–1110PubMedCrossRef Obrosova IG, Minchenko AG, Marinescu V et al (2001) Antioxidants attenuate early up regulation of retinal vascular endothelial growth factor in streptozotocin-diabetic rats. Diabetologia 44:1102–1110PubMedCrossRef
10.
Zurück zum Zitat Kowluru RA, Tang J, Kern TS (2001) Abnormalities of retinal metabolism in diabetes and experimental galactosemia. VII. Effect of long-term administration of antioxidants on the development of retinopathy. Diabetes 50:1938–1942PubMedCrossRef Kowluru RA, Tang J, Kern TS (2001) Abnormalities of retinal metabolism in diabetes and experimental galactosemia. VII. Effect of long-term administration of antioxidants on the development of retinopathy. Diabetes 50:1938–1942PubMedCrossRef
11.
Zurück zum Zitat Zheng L, Szabo C, Kern TS (2004) Poly(ADP-ribose) polymerase is involved in the development of diabetic retinopathy via regulation of nuclear factor-kappaB. Diabetes 53:2960–2967PubMedCrossRef Zheng L, Szabo C, Kern TS (2004) Poly(ADP-ribose) polymerase is involved in the development of diabetic retinopathy via regulation of nuclear factor-kappaB. Diabetes 53:2960–2967PubMedCrossRef
12.
Zurück zum Zitat Kador PF, Takahashi Y, Wyman M, Ferris F 3rd (1995) Diabetes-like proliferative retinal changes in galactose-fed dogs. Arch Ophthalmol 113:352–354PubMed Kador PF, Takahashi Y, Wyman M, Ferris F 3rd (1995) Diabetes-like proliferative retinal changes in galactose-fed dogs. Arch Ophthalmol 113:352–354PubMed
13.
Zurück zum Zitat Neuenschwander H, Takahashi Y, Kador PF (1997) Dose-dependent reduction of retinal vessel changes associated with diabetic retinopathy in galactose-fed dogs by the aldose reductase inhibitor M79175. J Ocular Pharmacol Ther 13:517–528CrossRef Neuenschwander H, Takahashi Y, Kador PF (1997) Dose-dependent reduction of retinal vessel changes associated with diabetic retinopathy in galactose-fed dogs by the aldose reductase inhibitor M79175. J Ocular Pharmacol Ther 13:517–528CrossRef
14.
Zurück zum Zitat Obrosova IG, Minchenko AG, Vasupuram R et al (2003) Aldose reductase inhibitor fidarestat prevents retinal oxidative stress and vascular endothelial growth factor overexpression in streptozotocin-diabetic rats. Diabetes 52:864–871PubMedCrossRef Obrosova IG, Minchenko AG, Vasupuram R et al (2003) Aldose reductase inhibitor fidarestat prevents retinal oxidative stress and vascular endothelial growth factor overexpression in streptozotocin-diabetic rats. Diabetes 52:864–871PubMedCrossRef
15.
Zurück zum Zitat Tilton RG, Chang K, Nyengaard JR, Van den Enden M, Ido Y, Williamson JR (1995) Inhibition of sorbitol dehydrogenase. Effects on vascular and neural dysfunction in streptozocin-induced diabetic rats. Diabetes 44:234–242PubMedCrossRef Tilton RG, Chang K, Nyengaard JR, Van den Enden M, Ido Y, Williamson JR (1995) Inhibition of sorbitol dehydrogenase. Effects on vascular and neural dysfunction in streptozocin-induced diabetic rats. Diabetes 44:234–242PubMedCrossRef
16.
Zurück zum Zitat Obrosova IG, Stevens MJ, Lang HJ (2001) Diabetes-induced changes in retinal NAD-redox status: pharmacological modulation and implications for pathogenesis of diabetic retinopathy. Pharmacology 62:172–180PubMedCrossRef Obrosova IG, Stevens MJ, Lang HJ (2001) Diabetes-induced changes in retinal NAD-redox status: pharmacological modulation and implications for pathogenesis of diabetic retinopathy. Pharmacology 62:172–180PubMedCrossRef
17.
Zurück zum Zitat Obrosova IG, Fathallah L, Greene DA (2000) Early changes in lipid peroxidation and antioxidative defense in diabetic rat retina: effect of dl-alpha-lipoic acid. Eur J Pharmacol 398:139–146PubMedCrossRef Obrosova IG, Fathallah L, Greene DA (2000) Early changes in lipid peroxidation and antioxidative defense in diabetic rat retina: effect of dl-alpha-lipoic acid. Eur J Pharmacol 398:139–146PubMedCrossRef
18.
Zurück zum Zitat Kowluru RA, Odenbach S (2004) Effect of long-term administration of alpha-lipoic acid on retinal capillary cell death and the development of retinopathy in diabetic rats. Diabetes 53:3233–3238PubMedCrossRef Kowluru RA, Odenbach S (2004) Effect of long-term administration of alpha-lipoic acid on retinal capillary cell death and the development of retinopathy in diabetic rats. Diabetes 53:3233–3238PubMedCrossRef
19.
Zurück zum Zitat Obrosova IG, Pacher P, Szabo C et al (2005) Aldose reductase inhibition counteracts oxidative–nitrosative stress and poly(ADP-ribose) polymerase activation in tissue sites for diabetes complications. Diabetes 54:234–242PubMedCrossRef Obrosova IG, Pacher P, Szabo C et al (2005) Aldose reductase inhibition counteracts oxidative–nitrosative stress and poly(ADP-ribose) polymerase activation in tissue sites for diabetes complications. Diabetes 54:234–242PubMedCrossRef
20.
Zurück zum Zitat Rota R, Chiavaroli C, Garay RP, Hannaert P (2004) Reduction of retinal albumin leakage by the antioxidant calcium dobesilate in streptozotocin-diabetic rats. Eur J Pharmacol 495:217–224PubMedCrossRef Rota R, Chiavaroli C, Garay RP, Hannaert P (2004) Reduction of retinal albumin leakage by the antioxidant calcium dobesilate in streptozotocin-diabetic rats. Eur J Pharmacol 495:217–224PubMedCrossRef
21.
Zurück zum Zitat Obrosova IG, Minchenko AG, Frank RN et al (2004) Poly(ADP-ribose) polymerase inhibitors counteract diabetes- and hypoxia-induced retinal vascular endothelial growth factor overexpression. Int J Mol Med 14:55–64PubMed Obrosova IG, Minchenko AG, Frank RN et al (2004) Poly(ADP-ribose) polymerase inhibitors counteract diabetes- and hypoxia-induced retinal vascular endothelial growth factor overexpression. Int J Mol Med 14:55–64PubMed
22.
Zurück zum Zitat Kowluru RA (2002) Retinal metabolic abnormalities in diabetic mouse: comparison with diabetic rat. Curr Eye Res 24:123–128PubMedCrossRef Kowluru RA (2002) Retinal metabolic abnormalities in diabetic mouse: comparison with diabetic rat. Curr Eye Res 24:123–128PubMedCrossRef
23.
Zurück zum Zitat Obrosova IG, Fathallah L, Lang HJ, Greene DA (1999) Evaluation of a sorbitol dehydrogenase inhibitor on diabetic peripheral nerve metabolism: a prevention study. Diabetologia 42:1187–1194PubMedCrossRef Obrosova IG, Fathallah L, Lang HJ, Greene DA (1999) Evaluation of a sorbitol dehydrogenase inhibitor on diabetic peripheral nerve metabolism: a prevention study. Diabetologia 42:1187–1194PubMedCrossRef
24.
Zurück zum Zitat Obrosova IG, Stevens MJ (1999) Effect of dietary taurine supplementation on GSH and NAD(P)-redox status, lipid peroxidation, and energy metabolism in diabetic precataractous lens. Invest Ophthalmol Vis Sci 40:680–688PubMed Obrosova IG, Stevens MJ (1999) Effect of dietary taurine supplementation on GSH and NAD(P)-redox status, lipid peroxidation, and energy metabolism in diabetic precataractous lens. Invest Ophthalmol Vis Sci 40:680–688PubMed
25.
Zurück zum Zitat Towbin H, Staehelin T, Gordon J (1992) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. 1979. Biotechnology 24:145–149PubMed Towbin H, Staehelin T, Gordon J (1992) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. 1979. Biotechnology 24:145–149PubMed
26.
Zurück zum Zitat Amano S, Yamagishi S, Kato N et al (2002) Sorbitol dehydrogenase overexpression potentiates glucose toxicity to cultured retinal pericytes. Biochem Biophys Res Commun 299:183–188PubMedCrossRef Amano S, Yamagishi S, Kato N et al (2002) Sorbitol dehydrogenase overexpression potentiates glucose toxicity to cultured retinal pericytes. Biochem Biophys Res Commun 299:183–188PubMedCrossRef
27.
Zurück zum Zitat Cheung AK, Fung MK, Lo AC et al (2005) Aldose reductase deficiency prevents diabetes-induced blood–retinal barrier breakdown, apoptosis, and glial reactivation in the retina of db/db mice. Diabetes 54:3119–3125PubMedCrossRef Cheung AK, Fung MK, Lo AC et al (2005) Aldose reductase deficiency prevents diabetes-induced blood–retinal barrier breakdown, apoptosis, and glial reactivation in the retina of db/db mice. Diabetes 54:3119–3125PubMedCrossRef
28.
Zurück zum Zitat Cruz JW, Oliveira MA, Hohman TC, Fortes ZB (2000) Influence of tolrestat on the defective leukocyte–endothelial interaction in experimental diabetes. Eur J Pharmacol 391:163–174PubMedCrossRef Cruz JW, Oliveira MA, Hohman TC, Fortes ZB (2000) Influence of tolrestat on the defective leukocyte–endothelial interaction in experimental diabetes. Eur J Pharmacol 391:163–174PubMedCrossRef
29.
Zurück zum Zitat Okayama N, Omi H, Okouchi M et al (2002) Mechanisms of inhibitory activity of the aldose reductase inhibitor, epalrestat, on high glucose-mediated endothelial injury: neutrophil-endothelial cell adhesion and surface expression of endothelial adhesion molecules. J Diabetes Complications 16:321–326PubMedCrossRef Okayama N, Omi H, Okouchi M et al (2002) Mechanisms of inhibitory activity of the aldose reductase inhibitor, epalrestat, on high glucose-mediated endothelial injury: neutrophil-endothelial cell adhesion and surface expression of endothelial adhesion molecules. J Diabetes Complications 16:321–326PubMedCrossRef
30.
Zurück zum Zitat Miwa K, Nakamura J, Hamada Y et al (2003) The role of polyol pathway in glucose-induced apoptosis of cultured retinal pericytes. Diabetes Res Clin Pract 60:1–9PubMedCrossRef Miwa K, Nakamura J, Hamada Y et al (2003) The role of polyol pathway in glucose-induced apoptosis of cultured retinal pericytes. Diabetes Res Clin Pract 60:1–9PubMedCrossRef
31.
Zurück zum Zitat Aukunuru JV, Sunkara G, Ayalasomayajula SP, DeRuiter J, Clark RC, Kompella UB (2002) A biodegradable injectable implant sustains systemic and ocular delivery of an aldose reductase inhibitor and ameliorates biochemical changes in a galactose-fed rat model for diabetic complications. Pharm Res 19:278–285PubMedCrossRef Aukunuru JV, Sunkara G, Ayalasomayajula SP, DeRuiter J, Clark RC, Kompella UB (2002) A biodegradable injectable implant sustains systemic and ocular delivery of an aldose reductase inhibitor and ameliorates biochemical changes in a galactose-fed rat model for diabetic complications. Pharm Res 19:278–285PubMedCrossRef
32.
Zurück zum Zitat Asnaghi V, Gerhardinger C, Hoehn T, Adeboje A, Lorenzi M (2003) A role for the polyol pathway in the early neuroretinal apoptosis and glial changes induced by diabetes in the rat. Diabetes 52:506–511PubMedCrossRef Asnaghi V, Gerhardinger C, Hoehn T, Adeboje A, Lorenzi M (2003) A role for the polyol pathway in the early neuroretinal apoptosis and glial changes induced by diabetes in the rat. Diabetes 52:506–511PubMedCrossRef
33.
Zurück zum Zitat Feit-Leichman RA, Kinouchi R, Takeda M et al (2005) Vascular damage in a mouse model of diabetic retinopathy: relation to neuronal and glial changes. Invest Ophthalmol Vis Sci 46:4281–4287PubMedCrossRef Feit-Leichman RA, Kinouchi R, Takeda M et al (2005) Vascular damage in a mouse model of diabetic retinopathy: relation to neuronal and glial changes. Invest Ophthalmol Vis Sci 46:4281–4287PubMedCrossRef
34.
Zurück zum Zitat Ellis EA, Grant MB, Murray FT et al (1998) Increased NADH oxidase activity in the retina of the BBZ/Wor diabetic rat. Free Radic Biol Med 24:111–120PubMedCrossRef Ellis EA, Grant MB, Murray FT et al (1998) Increased NADH oxidase activity in the retina of the BBZ/Wor diabetic rat. Free Radic Biol Med 24:111–120PubMedCrossRef
35.
Zurück zum Zitat Robison WG Jr, Jacot JL, Katz ML, Glover JP (2000) Retinal vascular changes induced by the oxidative stress of alpha-tocopherol deficiency contrasted with diabetic microangiopathy. J Ocul Pharmacol Ther 16:109–120PubMedCrossRef Robison WG Jr, Jacot JL, Katz ML, Glover JP (2000) Retinal vascular changes induced by the oxidative stress of alpha-tocopherol deficiency contrasted with diabetic microangiopathy. J Ocul Pharmacol Ther 16:109–120PubMedCrossRef
36.
Zurück zum Zitat Rota R, Chiavaroli C, Garay RP, Hannaert P (2004) Reduction of retinal albumin leakage by the antioxidant calcium dobesilate in streptozotocin-diabetic rats. Eur J Pharmacol 495:217–224PubMedCrossRef Rota R, Chiavaroli C, Garay RP, Hannaert P (2004) Reduction of retinal albumin leakage by the antioxidant calcium dobesilate in streptozotocin-diabetic rats. Eur J Pharmacol 495:217–224PubMedCrossRef
37.
Zurück zum Zitat Purves T, Middlemas A, Agthong S et al (2001) A role for mitogen-activated protein kinases in the etiology of diabetic neuropathy. FASEB J 15:2508–2514PubMedCrossRef Purves T, Middlemas A, Agthong S et al (2001) A role for mitogen-activated protein kinases in the etiology of diabetic neuropathy. FASEB J 15:2508–2514PubMedCrossRef
38.
Zurück zum Zitat Romeo G, Liu WH, Asnaghi V, Kern TS, Lorenzi M (2002) Activation of nuclear factor-kappaB induced by diabetes and high glucose regulates a proapoptotic program in retinal pericytes. Diabetes 51:2241–2248PubMedCrossRef Romeo G, Liu WH, Asnaghi V, Kern TS, Lorenzi M (2002) Activation of nuclear factor-kappaB induced by diabetes and high glucose regulates a proapoptotic program in retinal pericytes. Diabetes 51:2241–2248PubMedCrossRef
39.
Zurück zum Zitat Li F, Obrosova IG, Abatan O et al (2005) Taurine replacement attenuates hyperalgesia and abnormal calcium signaling in sensory neurons of STZ-D rats. Am J Physiol Endocrinol Metab 288:E29–E36PubMedCrossRef Li F, Obrosova IG, Abatan O et al (2005) Taurine replacement attenuates hyperalgesia and abnormal calcium signaling in sensory neurons of STZ-D rats. Am J Physiol Endocrinol Metab 288:E29–E36PubMedCrossRef
40.
Zurück zum Zitat Joussen AM, Poulaki V, Le ML et al (2004) A central role for inflammation in the pathogenesis of diabetic retinopathy. FASEB J 18:1450–1452PubMed Joussen AM, Poulaki V, Le ML et al (2004) A central role for inflammation in the pathogenesis of diabetic retinopathy. FASEB J 18:1450–1452PubMed
41.
Zurück zum Zitat Jagtap P, Szabo C (2005) Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors. Nat Rev Drug Discov 4:421–440PubMedCrossRef Jagtap P, Szabo C (2005) Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors. Nat Rev Drug Discov 4:421–440PubMedCrossRef
42.
Zurück zum Zitat Sugawara R, Hikichi T, Kitaya N et al (2004) Peroxynitrite decomposition catalyst, FP15, and poly(ADP-ribose) polymerase inhibitor, PJ34, inhibit leukocyte entrapment in the retinal microcirculation of diabetic rats. Curr Eye Res 29:11–16PubMedCrossRef Sugawara R, Hikichi T, Kitaya N et al (2004) Peroxynitrite decomposition catalyst, FP15, and poly(ADP-ribose) polymerase inhibitor, PJ34, inhibit leukocyte entrapment in the retinal microcirculation of diabetic rats. Curr Eye Res 29:11–16PubMedCrossRef
43.
Zurück zum Zitat Williamson JR, Chang K, Frangos M et al (1993) Hyperglycemic pseudohypoxia and diabetic complications. Diabetes 42:801–813PubMedCrossRef Williamson JR, Chang K, Frangos M et al (1993) Hyperglycemic pseudohypoxia and diabetic complications. Diabetes 42:801–813PubMedCrossRef
Metadaten
Titel
Early diabetes-induced biochemical changes in the retina: comparison of rat and mouse models
verfasst von
I. G. Obrosova
V. R. Drel
A. K. Kumagai
C. Szábo
P. Pacher
M. J. Stevens
Publikationsdatum
01.10.2006
Verlag
Springer-Verlag
Erschienen in
Diabetologia / Ausgabe 10/2006
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-006-0356-7

Weitere Artikel der Ausgabe 10/2006

Diabetologia 10/2006 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.